[1]
Agarwal, R., Goel, A., Rai, J. and Kajal, N.C. 2017. Pharmacovigilance of first line anti-tubercular therapy in category I patients of pulmonary tuberculosis. International Journal of Basic & Clinical Pharmacology. 6, 3 (Feb. 2017), 643–647. DOI:https://doi.org/10.18203/2319-2003.ijbcp20170829.